Form 8-K - Current report:
SEC Accession No. 0001213900-25-051166
Filing Date
2025-06-04
Accepted
2025-06-04 16:16:55
Documents
15
Period of Report
2025-06-04
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ea0244725-8k_rafael.htm   iXBRL 8-K 37573
2 PRESS RELEASE ea0244725ex99-1_rafael.htm EX-99.1 8045
3 GRAPHIC image_001.jpg GRAPHIC 3764
  Complete submission text file 0001213900-25-051166.txt   265947

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rfl-20250506.xsd EX-101.SCH 3777
5 XBRL DEFINITION FILE rfl-20250506_def.xml EX-101.DEF 26617
6 XBRL LABEL FILE rfl-20250506_lab.xml EX-101.LAB 36669
7 XBRL PRESENTATION FILE rfl-20250506_pre.xml EX-101.PRE 25241
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0244725-8k_rafael_htm.xml XML 5666
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-38411 | Film No.: 251023314
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)